Inspire Medical Systems (NYSE:INSP – Get Free Report) and Sensus Healthcare (NASDAQ:SRTS – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations.
Institutional & Insider Ownership
94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Volatility & Risk
Inspire Medical Systems has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.
Profitability
This table compares Inspire Medical Systems and Sensus Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inspire Medical Systems | 11.43% | 7.32% | 6.39% |
| Sensus Healthcare | -88.45% | -21.57% | -19.20% |
Earnings and Valuation
This table compares Inspire Medical Systems and Sensus Healthcare”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inspire Medical Systems | $911.98 million | 1.93 | $145.42 million | $3.44 | 17.62 |
| Sensus Healthcare | $27.48 million | 1.51 | -$7.72 million | ($0.94) | -2.67 |
Inspire Medical Systems has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Inspire Medical Systems and Sensus Healthcare, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inspire Medical Systems | 4 | 12 | 3 | 1 | 2.05 |
| Sensus Healthcare | 1 | 0 | 4 | 0 | 2.60 |
Inspire Medical Systems currently has a consensus price target of $71.24, indicating a potential upside of 17.53%. Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 132.03%. Given Sensus Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Inspire Medical Systems.
Summary
Inspire Medical Systems beats Sensus Healthcare on 10 of the 15 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy. Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company focused on non-invasive treatment technologies for dermatologic and oncologic conditions. The company develops and commercializes superficial radiotherapy systems designed to deliver low-energy X-rays to targeted areas of the skin. Its principal products include the SRT-100 and SRT-100 Vision systems, which are used by physicians to treat non-melanoma skin cancers, including basal cell and squamous cell carcinomas, as well as keloids. The systems are intended to provide an alternative to certain surgical procedures and are used in dermatology, radiation oncology and other clinical settings.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
